Abstract
Background
Incidence of venous thromboembolism (VTE) following hepatectomy for colorectal cancer (CRC) metastases is unclear. These patients may represent a vulnerable population due to increased tumour burden. We aim to identify the risk of VTE development in routine clinical practice among patients with resected CRC liver metastases, the associated risk factors, and its impact on survival.
Methods
We conducted a population-based retrospective cohort study of Ontario patients undergoing hepatectomy for CRC metastases between 2002 and 2009 using linked universal healthcare databases. Multivariable logistic regression was used to estimate the association between patient characteristics and VTE risk at 30 and 90-days after surgery. Cox proportional-hazards regression was used to estimate the association between VTE and adjusted cancer specific (CSS) and overall survival (OS).
Results
1310 patients were included with a mean age of 63 ± 11. 62% were male. 51% had one metastatic deposit. Major hepatectomy occurred in 64%. VTE occurred in 4% within 90 days of liver resection. Only longer length of stay was associated with VTE development (OR 6.88 (2.57–18.43), p <0.001 for 15–21 days versus 0–7 days). 38% of VTEs were diagnosed after discharge, comprising 1.52% of the total cohort. VTE was not associated with inferior CSS or OS.
Conclusions
Risk of VTE development in this population is similar to those undergoing hepatectomy for other indications, and to the risk following other cancer site resections where post-operative extended VTE prophylaxis is currently recommended. The number of VTEs occurring after discharge suggests there may be a role for extended VTE prophylaxis.
Similar content being viewed by others
References
Anderson FA Jr, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107:I9-16
Heit JA (2003) Risk factors for venous thromboembolism. Clin Chest Med 24:1–12
Goldhaber SZ (2010) Risk factors for venous thromboembolism. J Am Coll Cardiol 56:1–7
Agnelli G, Bolis G, Capussotti L et al (2006) A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 243:89–95
Ruppert A, Steinle T, Lees M (2011) Economic burden of venous thromboembolism: a systematic review. J Med Econ 14:65–74
Gould MK, Garcia DA, Wren SM et al (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic Therapy and prevention of Thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest 141:e227S-e277S
Cronin M, Dengler N, Krauss ES et al (2019) Completion of the updated caprini risk assessment model (2013 Version). Clin Appl Thromb Hemost 25:1076029619838052
Bellini G, Teng A, Kotecha N et al (2016) The identification of risk factors for venous thromboembolism in gastrointestinal oncologic surgery. J Surg Res 205:279–285
Newhook TE, LaPar DJ, Walters DM et al (2015) Impact of Postoperative venous thromboembolism on postoperative morbidity, mortality, and resource utilization after hepatectomy. Am Surg 81:1216–1223
Stewart GD, O’Súilleabháin CB, Madhavan KK et al (2004) The extent of resection influences outcome following hepatectomy for colorectal liver metastases. Eur J Surg Oncol 30:370–376
Dimick JB, Cowan JA Jr, Knol JA et al (2003) Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg 138:185–191
Morris-Stiff G, White A, Gomez D et al (2008) Thrombotic complications following liver resection for colorectal metastases are preventable. HPB (Oxford) 10:311–314
Robles SC, Marrett LD, Clarke EA et al (1988) An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol 41:495–501
Booth CM, Li G, Zhang-Salomons J et al (2010) The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population-based study in Ontario, Canada. Cancer 116:4160–4167
von Elm E, Altman DG, Egger M et al (2014) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg 12:1495–1499
Nanji S, Mackillop WJ, Wei X et al (2017) Simultaneous resection of primary colorectal cancer and synchronous liver metastases: a population-based study. Can J Surg 60:122–128
Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613–619
Patel SV, Zhang L, Wei XS et al (2020) A population-based cohort study of venous thromboembolism rates following surgery and during adjuvant chemotherapy in patients with colon cancer. Dis Colon Rectum 63:336–345
Doiron RC, Booth CM, Wei X et al (2016) Risk factors and timing of venous thromboembolism after radical cystectomy in routine clinical practice: a population-based study. BJU Int 118:714–722
Ejaz A, Spolverato G, Kim Y et al (2014) Defining incidence and risk factors of venous thromboemolism after hepatectomy. J Gastrointest Surg 18:1116–1124
Tzeng C-WDWD, Katz MHG, Fleming JB et al (2012) Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB 14:506–513
Lim SH, Woo SY, Kim S et al (2016) Cross-sectional study of patients with diffuse large B-Cell Lymphoma: assessing the effect of host status, tumor burden, and inflammatory activity on venous thromboembolism. Cancer Res Treat 48:312–321
Zhang W, Liu X, Cheng H et al (2018) Risk factors and treatment of venous thromboembolism in perioperative patients with ovarian cancer in China. Medicine (Baltimore) 97:e11754
Matsuo K, Ross MS, Im DD et al (2018) Significance of venous thromboembolism in women with uterine carcinosarcoma. Gynecol Oncol 148:267–274
Hanna N, Bikov KA, McNally D et al (2012) Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancer. Oncologist 17:1191–1197
Ren W, Sell NM, Ferrone CR et al (2021) Size of the largest colorectal liver metastasis is an independent prognostic factor in the neoadjuvant setting. J Surg Res 259:253–260
Wei AC, Greig PD, Grant D et al (2006) Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol 13:668–676
Roberts KJ, White A, Cockbain A et al (2014) Performance of prognostic scores in predicting long-term outcome following resection of colorectal liver metastases. Br J Surg 101:856–866
Tzeng CWD, Curley SA, Vauthey JN et al (2013) Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients. HPB 15:773–780
Harron K, Dibben C, Boyd J et al (2017) Challenges in administrative data linkage for research. Big Data Soc 4:2053951717745678–2053951717745678
Weiss MJ, Kim Y, Ejaz A et al (2014) Venous thromboembolic prophylaxis after a hepatic resection: patterns of care among liver surgeons. HPB (Oxford) 16:892–898
Ruff SM, Ayabe RI, Wach MM et al (2019) Practice patterns of VTE chemoprophylaxis after discharge following hepatic and pancreatic resections for cancer: a survey of hepatopancreatobiliary surgeons. J Thromb Thrombolysis 48:119–124
Kim BJ, Day RW, Davis CH et al (2017) Extended pharmacologic thromboprophylaxis in oncologic liver surgery is safe and effective. J Thromb Haemost 15:2158–2164
Low DE, Allum W, De Manzoni G et al (2019) Guidelines for perioperative care in esophagectomy: enhanced recovery after surgery (ERAS(®)) society recommendations. World J Surg 43:299–330. https://doi.org/10.1007/s00268-018-4786-4
Mortensen K, Nilsson M, Slim K et al (2014) Consensus guidelines for enhanced recovery after gastrectomy: enhanced Recovery After Surgery (ERAS®) Society recommendations. Br J Surg 101:1209–1229
Acknowledgements
This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health (MOH) and the Ministry of Long-Term Care (MLTC). Parts of this material are based on data and information compiled and provided by MOH, MLTC, CIHI, OHIP, ODB and OCR. The analyses, conclusions, opinions, and statements expressed herein are solely those of the authors and do not reflect those of the data sources; no endorsement is intended nor should be inferred. We thank IMS Brogan Inc. for use of their Drug Information Database.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hanna, N., Brogly, S.B., Wei, X.S. et al. Incidence and Risk Factors of Venous Thromboembolism Following Hepatectomy for Colorectal Metastases: A Population-Based Retrospective Cohort Study. World J Surg 46, 180–188 (2022). https://doi.org/10.1007/s00268-021-06316-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-021-06316-9